Sign in
Enrolling by invitationNo phase

Studying filaggrin gene changes in Latinx patients with atopic dermatitis

Looks at filaggrin gene changes and atopic dermatitis in Latinx patients.

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
Status
Enrolling by invitation
People taking part
300 people, planned
Started
23 Jan 2025
Expected to end
31 Dec 2027
Type of study
Observational
Record updated
24 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with atopic dermatitis (eczema) who identify as Latino/Latinx or Hispanic. It studies filaggrin gene changes in this group.

Sex
All sexes can join.
Disease stage
Atopic dermatitis diagnosed by a doctor, present for at least one year.
Biomarker or test result
The study looks at filaggrin (FLG) gene variants. The record does not ask for a specific test result to join.

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Established diagnosis of AD based on physician report of at least one-year duration
  • Self-identification as Latino/Latinx or Hispanic

Who cannot take part

  • -

Where in United States

  • The University of PennsylvaniaPhiladelphia, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The study, Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis, will examine the association between pathogenic FLG LOF variants and AD in a new population of Latinx patients for which clinical and disease characteristics will be well-described.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
Plain-language title
Studying filaggrin gene changes in Latinx patients with atopic dermatitisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
24 April 2026